Regeneron
Trade Regeneron 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About REGN
Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. Its product portfolio includes the following brands: Dupixent, Evkeeza, Eylea, Inmazeb, and Kevzara.
REGN Key Statistics
REGN News
Regeneron Pharmaceuticals, Inc. REGN on Tuesday announced five-year follow-up results on overall survival (OS) from the Phase 3 EMPOWER-Lung 3 trial of Libtayo...
In a report released yesterday, Evan Seigerman from BMO Capital maintained a Buy rating on Regeneron, with a price target of $640.00. Elevate Your Investing Str...
Regeneron (REGN) Pharmaceuticals announced five-year follow-up results on overall survival from the Phase 3 EMPOWER-Lung 3 trial, which evaluated Libtayo plus p...
Analyst ratings
79%
of 28 ratingsMore REGN News
Sandoz (SDZNY) announced that it has reached an agreement with Regeneron Pharmaceuticals (REGN), to resolve all patent disputes between the two companies relati...
Regeneron Pharmaceuticals, Inc. REGN revealed data from Phase 3 trials in adults with moderate-to-severe cat or birch allergies on Monday. Both trials met their...
Regeneron (REGN) announced results evaluating its nvestigational allergen-blocking antibodies in allergen-challenge Phase 3 trials in adults with moderate-to-se...
Regeneron Pharmaceuticals ((REGN)) announced an update on their ongoing clinical study. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at...
Regeneron Pharmaceuticals ((REGN)) announced an update on their ongoing clinical study. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at...
Regeneron Pharmaceuticals ((REGN)) announced an update on their ongoing clinical study. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at...
Regeneron Pharmaceuticals ((REGN)) announced an update on their ongoing clinical study. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 5...